Mantle cell lymphoma in the bone marrow may appear similar to other lymphoproliferative disorders. Immunohistochemical staining for cyclin D1 is helpful in diagnosing this entity.
With a median survival rate of 5-7 yrs, Mantle Cell Lymphoma (MCL) is considered the most aggressive known blood cancer – and available therapies are scarce. 3000 Americans are diagnosed with MCL every year. Tel Aviv University researchers offer tangible hope of curing the currently incurable blood cancer – and others like it. The revolutionary system was found to successfully halt the proliferation of a cancer-related protein in WBCs in both animal models and samples taken from MCL patients.
“MCL has a genetic hallmark,” said Dr. Peer...
Read More
Recent Comments